INPATIENT USE OF BENRALIZUMAB IN ACUTE SEVERE EOSINOPHILIC ASTHMA

被引：0
|
作者：
Toth, Stephen
Pruett, William M.
机构：
来源：
CHEST | 2024年 / 166卷 / 04期
关键词：
D O I：
10.1016/j.chest.2024.06.067
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：79A / 79A
页数：1
相关论文
共 50 条
  • [31] Mepolizumab and Benralizumab in Severe Eosinophilic Asthma: Preliminary Results of a Proteomic Study
    Vantaggiato, Lorenza
    Perruzza, Marco
    Refini, Rosa Metella
    Bergantini, Laura
    D'Alessandro, Miriana
    Cameli, Paolo
    Perruzza, Davide
    Bini, Luca
    Bargagli, Elena
    Landi, Claudia
    LUNG, 2020, 198 (05) : 761 - 765
  • [32] Benralizumab for severe asthma associated with extra-airway eosinophilic diseases
    Toyoshima, Mikio
    Koda, Keigo
    Nozue, Tsuyoshi
    Suda, Takafumi
    EUROPEAN RESPIRATORY JOURNAL, 2020, 56
  • [33] REAL LIFE EXPERIENCE WITH BENRALIZUMAB IN PATIENTS WITH SEVERE UNCONTROLLED EOSINOPHILIC ASTHMA
    Murphy, E.
    Diaz, J.
    Singh, H.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2019, 123 (05) : S36 - S37
  • [34] Efficacy and safety of benralizumab in Japanese patients with severe, uncontrolled eosinophilic asthma
    Ohta, Ken
    Adachi, Mitsuru
    Tohda, Yuji
    Kamei, Tadashi
    Kato, Motokazu
    Fitzgerald, J. Mark
    Takanuma, Masayuki
    Kakuno, Tadahiro
    Imai, Nobuyuki
    Wu, Yanping
    Aurivillius, Magnus
    Goldman, Mitchell
    ALLERGOLOGY INTERNATIONAL, 2018, 67 (02) : 266 - 272
  • [35] The relationship between FENO and effectiveness of mepolizumab and benralizumab in severe eosinophilic asthma
    Hearn, Andrew P.
    Kavanagh, Joanne
    d'Ancona, Grainne
    Roxas, Cris
    Green, Linda
    Thomson, Louise
    Fernandes, Marianna
    Kent, Brian D.
    Dhariwal, Jaideep
    Nanzer, Alexanda M.
    Jackson, David J.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2021, 9 (05): : 2093 - +
  • [36] Comprehensive Response to Benralizumab by Patients with Nasal Polyposis and Severe, Eosinophilic Asthma
    Kreindler, J.
    Chanez, P.
    Bourdin, A.
    Burden, A.
    Gil, Garcia E. G.
    PNEUMOLOGIE, 2021, 75 : S34 - S35
  • [37] Cycling therapy with benralizumab and dupilumab for severe eosinophilic asthma with eosinophilic chronic rhinosinusitis and eosinophilic otitis media
    Hamada, Satoshi
    Ogino, Eriko
    Yasuba, Hirotaka
    ALLERGOLOGY INTERNATIONAL, 2021, 70 (03) : 389 - 391
  • [38] Mepolizumab and benralizumab in patients with severe asthma and a history of eosinophilic granulomatosis with polyangiitis
    Desaintjean, Charlene
    Ahmad, Kais
    Traclet, Julie
    Gerfaud-Valentin, Mathieu
    Durel, Cecile-Audrey
    Glerant, Jean-Charles
    Hot, Arnaud
    Lestelle, Francois
    Mainbourg, Sabine
    Nasser, Mouhamad
    Seve, Pascal
    Turquier, Segolene
    Devouassoux, Gilles
    Cottin, Vincent
    FRONTIERS IN MEDICINE, 2024, 11
  • [39] Mepolizumab and Benralizumab in Severe Eosinophilic Asthma: Preliminary Results of a Proteomic Study
    Lorenza Vantaggiato
    Marco Perruzza
    Rosa Metella Refini
    Laura Bergantini
    Miriana d’Alessandro
    Paolo Cameli
    Davide Perruzza
    Luca Bini
    Elena Bargagli
    Claudia Landi
    Lung, 2020, 198 : 761 - 765
  • [40] Comparison of Clinical Efficacy Between Mepolizumab and Benralizumab in Severe Eosinophilic Asthma
    Okawa, K.
    Akamatsu, T.
    Sugiyama, S.
    Shiratori, K.
    Nakayasu, H.
    Masuda, T.
    Takahashi, S.
    Kitahara, Y.
    Kishimoto, Y.
    Sakurai, S.
    Saigusa, M.
    Yamamoto, A.
    Morita, S.
    Asada, K.
    Shirai, T.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2022, 205
12345